Home › Boehringer Ingelheim Selects Medidata Clinical Cloud To Accelerate Innovation In Drug Development
 

Keywords :   


Boehringer Ingelheim Selects Medidata Clinical Cloud To Accelerate Innovation In Drug Development

2015-12-22 01:49:44| drugdiscoveryonline Home Page

Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Boehringer Ingelheim has selected the Medidata Clinical Cloudto accelerate innovation across all of its drug development programs.

Tags: development drug clinical innovation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.05Weekly Recap: Huggies Launches Skin Essentials Diaper, P&G Recognizes Key Suppliers & More
12.05California Bill Limits Skincare Sales to Teens & Persil Rebrands
12.05Kline Analysts Detail the Medical Dispensing Skin Care Market
12.05Glo30 Starts 2024 Strong with 60% Growth
12.05Zevo On-Body Repellent Teams with American Hiking Society To Provide Bug Bite Defense
12.05L\'Oréals Brand Value Soars to $13.4 Billion
12.05Spate Unveils the Top Sustainability Trends Cycling Google Searches
12.05Oh K! is the Most Searched Beauty Brand in the World: Cosmetify
More »